• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

退伍军人事务部心脏风险评分:重新校准用于实际应用的动脉粥样硬化性心血管疾病评分。

The Veterans Affairs Cardiac Risk Score: Recalibrating the Atherosclerotic Cardiovascular Disease Score for Applied Use.

作者信息

Sussman Jeremy B, Wiitala Wyndy L, Zawistowski Matthew, Hofer Timothy P, Bentley Douglas, Hayward Rodney A

机构信息

*Veterans Affairs Center for Clinical Management Research †Department of Internal Medicine and Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI.

出版信息

Med Care. 2017 Sep;55(9):864-870. doi: 10.1097/MLR.0000000000000781.

DOI:10.1097/MLR.0000000000000781
PMID:28763374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5561663/
Abstract

BACKGROUND

Accurately estimating cardiovascular risk is fundamental to good decision-making in cardiovascular disease (CVD) prevention, but risk scores developed in one population often perform poorly in dissimilar populations. We sought to examine whether a large integrated health system can use their electronic health data to better predict individual patients' risk of developing CVD.

METHODS

We created a cohort using all patients ages 45-80 who used Department of Veterans Affairs (VA) ambulatory care services in 2006 with no history of CVD, heart failure, or loop diuretics. Our outcome variable was new-onset CVD in 2007-2011. We then developed a series of recalibrated scores, including a fully refit "VA Risk Score-CVD (VARS-CVD)." We tested the different scores using standard measures of prediction quality.

RESULTS

For the 1,512,092 patients in the study, the Atherosclerotic cardiovascular disease risk score had similar discrimination as the VARS-CVD (c-statistic of 0.66 in men and 0.73 in women), but the Atherosclerotic cardiovascular disease model had poor calibration, predicting 63% more events than observed. Calibration was excellent in the fully recalibrated VARS-CVD tool, but simpler techniques tested proved less reliable.

CONCLUSIONS

We found that local electronic health record data can be used to estimate CVD better than an established risk score based on research populations. Recalibration improved estimates dramatically, and the type of recalibration was important. Such tools can also easily be integrated into health system's electronic health record and can be more readily updated.

摘要

背景

准确估计心血管疾病风险是心血管疾病(CVD)预防中做出良好决策的基础,但在某一人群中开发的风险评分在不同人群中往往表现不佳。我们试图研究一个大型综合医疗系统是否可以利用其电子健康数据更好地预测个体患者发生CVD的风险。

方法

我们使用了所有年龄在45 - 80岁、于2006年使用退伍军人事务部(VA)门诊护理服务且无CVD、心力衰竭或袢利尿剂病史的患者组成队列。我们的结局变量是2007 - 2011年新发的CVD。然后我们开发了一系列重新校准的评分,包括完全重新拟合的“VA心血管疾病风险评分(VARS - CVD)”。我们使用预测质量的标准指标测试了不同的评分。

结果

对于研究中的1,512,092名患者,动脉粥样硬化性心血管疾病风险评分与VARS - CVD具有相似的辨别力(男性的c统计量为0.66,女性为0.73),但动脉粥样硬化性心血管疾病模型校准不佳,预测的事件比观察到的多63%。在完全重新校准的VARS - CVD工具中校准效果极佳,但测试的更简单技术证明可靠性较低。

结论

我们发现,与基于研究人群建立的风险评分相比,本地电子健康记录数据可用于更好地估计CVD。重新校准显著改善了估计,并且重新校准的类型很重要。此类工具还可以轻松集成到医疗系统的电子健康记录中,并且可以更轻松地更新。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffdc/5561663/79994f3bc5f7/nihms884086f1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffdc/5561663/79994f3bc5f7/nihms884086f1a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffdc/5561663/79994f3bc5f7/nihms884086f1a.jpg

相似文献

1
The Veterans Affairs Cardiac Risk Score: Recalibrating the Atherosclerotic Cardiovascular Disease Score for Applied Use.退伍军人事务部心脏风险评分:重新校准用于实际应用的动脉粥样硬化性心血管疾病评分。
Med Care. 2017 Sep;55(9):864-870. doi: 10.1097/MLR.0000000000000781.
2
Developing an Internally Validated Veterans Affairs Women Cardiovascular Disease Risk Score Using Veterans Affairs National Electronic Health Records.利用退伍军人事务部国家电子健康记录开发内部验证的退伍军人事务部女性心血管疾病风险评分。
J Am Heart Assoc. 2021 Feb;10(5):e019217. doi: 10.1161/JAHA.120.019217. Epub 2021 Feb 23.
3
Assessing Performance of the Veterans Affairs Women Cardiovascular Risk Model in Predicting a Short-Term Risk of Cardiovascular Disease Incidence Using United States Veterans Affairs COVID-19 Shared Data.利用美国退伍军人事务部 COVID-19 共享数据评估退伍军人事务部女性心血管风险模型预测短期心血管疾病发病风险的性能。
Int J Environ Res Public Health. 2021 Sep 23;18(19):10005. doi: 10.3390/ijerph181910005.
4
Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.澳大利亚人群中SCORE风险图表的重新校准与验证:澳大利亚SCORE图表
Eur J Cardiovasc Prev Rehabil. 2009 Oct;16(5):562-70. doi: 10.1097/HJR.0b013e32832cd9cb.
5
Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world.在世界多个地区验证非实验室和实验室为基础的心血管疾病风险评分的预后。
Heart. 2018 Apr;104(7):581-587. doi: 10.1136/heartjnl-2017-311609. Epub 2017 Oct 24.
6
An evaluation of the performance of SCORE Sweden 2015 in estimating cardiovascular risk: The Northern Sweden MONICA Study 1999-2014.2015年瑞典SCORE模型在评估心血管疾病风险方面的性能评估:1999 - 2014年瑞典北部莫尼卡研究
Eur J Prev Cardiol. 2017 Jan;24(1):103-110. doi: 10.1177/2047487316673142. Epub 2016 Oct 5.
7
Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.类风湿关节炎特异性心血管风险评分并不优于一般风险评分:一项对来自七个国家患者的验证分析。
Rheumatology (Oxford). 2017 Jul 1;56(7):1102-1110. doi: 10.1093/rheumatology/kex038.
8
Development of an Australian cardiovascular disease mortality risk score using multiple imputation and recalibration from national statistics.利用多重填补法和国家统计数据重新校准制定澳大利亚心血管疾病死亡风险评分
BMC Cardiovasc Disord. 2017 Jan 6;17(1):17. doi: 10.1186/s12872-016-0462-5.
9
Differential Impact of Aging on Cardiovascular Risk in Women Military Service Members.女性军人中衰老对心血管风险的差异影响。
J Am Heart Assoc. 2020 Jun 16;9(12):e015087. doi: 10.1161/JAHA.120.015087. Epub 2020 Jun 9.
10
Predicted Versus Observed Major Adverse Cardiac Event Risk in Women With Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women's Ischemia Syndrome Evaluation).有缺血证据且无阻塞性冠状动脉疾病的女性患者中预测与观察到的主要不良心脏事件风险:WISE(女性缺血综合征评估)的报告。
J Am Heart Assoc. 2020 Apr 7;9(7):e013234. doi: 10.1161/JAHA.119.013234. Epub 2020 Apr 9.

引用本文的文献

1
An Evidence Map of the Women Veterans' Health Literature, 2016 to 2023: A Systematic Review.2016年至2023年女性退伍军人健康文献证据图谱:一项系统综述
JAMA Netw Open. 2025 Apr 1;8(4):e256372. doi: 10.1001/jamanetworkopen.2025.6372.
2
Obesity Is Increasing in Liver Transplant Recipients and Exacerbates Cardiovascular Risk: A Single-Centre European Study.肝移植受者肥胖率上升并加剧心血管风险:一项欧洲单中心研究
Obes Surg. 2024 Dec;34(12):4442-4451. doi: 10.1007/s11695-024-07553-2. Epub 2024 Nov 5.
3
Coronary Disease Risk Prediction, Risk Reduction, and Postoperative Myocardial Injury.

本文引用的文献

1
Calibration of the Pooled Cohort Equations for Atherosclerotic Cardiovascular Disease: An Update.动脉粥样硬化性心血管疾病 pooled 队列方程的校准:更新。
Ann Intern Med. 2016 Dec 6;165(11):786-794. doi: 10.7326/M16-1739. Epub 2016 Oct 11.
2
Prediction models for cardiovascular disease risk in the general population: systematic review.普通人群心血管疾病风险预测模型:系统评价
BMJ. 2016 May 16;353:i2416. doi: 10.1136/bmj.i2416.
3
Validity of Diagnostic Codes for Acute Stroke in Administrative Databases: A Systematic Review.
冠状动脉疾病风险预测、风险降低和术后心肌损伤。
Med Clin North Am. 2024 Nov;108(6):1039-1051. doi: 10.1016/j.mcna.2024.06.003. Epub 2024 Jul 16.
4
Recalibrating the Genetics and Epidemiology of Colorectal Cancer Consortium Environmental Risk Score for Use in US Veterans.重新校准用于美国退伍军人的结直肠癌联盟遗传和环境风险评分的遗传学和流行病学。
Cancer Epidemiol Biomarkers Prev. 2024 Nov 1;33(11):1456-1464. doi: 10.1158/1055-9965.EPI-24-0791.
5
Back to the Basics in Predictive Modeling-Predicting Surgical Success.回归预测模型的基础——预测手术成功率。
Epilepsy Curr. 2023 Nov 6;24(1):19-21. doi: 10.1177/15357597231205437. eCollection 2024 Jan-Feb.
6
EXIST: EXamining rIsk of excesS adiposiTy-Machine learning to predict obesity-related complications.EXIST:检查超重肥胖风险——用于预测肥胖相关并发症的机器学习
Obes Sci Pract. 2023 Sep 13;10(1):e707. doi: 10.1002/osp4.707. eCollection 2024 Feb.
7
Uses of Social Determinants of Health Data to Address Cardiovascular Disease and Health Equity: A Scoping Review.利用健康的社会决定因素数据解决心血管疾病和健康公平问题:范围综述。
J Am Heart Assoc. 2023 Nov 7;12(21):e030571. doi: 10.1161/JAHA.123.030571. Epub 2023 Nov 6.
8
Polygenic Risk Scores for Cardiovascular Disease: A Scientific Statement From the American Heart Association.多基因风险评分与心血管疾病:美国心脏协会科学声明
Circulation. 2022 Aug 23;146(8):e93-e118. doi: 10.1161/CIR.0000000000001077. Epub 2022 Jul 18.
9
Risk prediction models for atherosclerotic cardiovascular disease: A systematic assessment with particular reference to Qatar.动脉粥样硬化性心血管疾病的风险预测模型:一项特别针对卡塔尔的系统评估
Qatar Med J. 2021 Sep 26;2021(2):42. doi: 10.5339/qmj.2021.42. eCollection 2021.
10
Using Prescription Drug Monitoring Program Data to Assess Likelihood of Incident Long-Term Opioid Use: a Statewide Cohort Study.利用处方药物监测计划数据评估新发长期阿片类药物使用的可能性:一项全州队列研究。
J Gen Intern Med. 2021 Dec;36(12):3672-3679. doi: 10.1007/s11606-020-06555-x. Epub 2021 Mar 19.
行政数据库中急性卒中诊断编码的有效性:一项系统评价。
PLoS One. 2015 Aug 20;10(8):e0135834. doi: 10.1371/journal.pone.0135834. eCollection 2015.
4
Improving diabetes prevention with benefit based tailored treatment: risk based reanalysis of Diabetes Prevention Program.通过基于获益的个性化治疗改善糖尿病预防:糖尿病预防计划的基于风险的重新分析
BMJ. 2015 Feb 19;350:h454. doi: 10.1136/bmj.h454.
5
Comparing cardiovascular risk prediction scores.比较心血管疾病风险预测评分。
Ann Intern Med. 2015 Feb 17;162(4):313-4. doi: 10.7326/M14-2820.
6
Death certificates underestimate infections as proximal causes of death in the U.S.在美国,死亡证明将感染作为死亡的直接原因的情况估计不足。
PLoS One. 2014 May 30;9(5):e97714. doi: 10.1371/journal.pone.0097714. eCollection 2014.
7
Validity of myocardial infarction diagnoses in administrative databases: a systematic review.行政数据库中心肌梗死诊断的有效性:一项系统评价。
PLoS One. 2014 Mar 28;9(3):e92286. doi: 10.1371/journal.pone.0092286. eCollection 2014.
8
Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3).英国联合学会关于预防心血管疾病的共识建议(JBS3)。
Heart. 2014 Apr;100 Suppl 2:ii1-ii67. doi: 10.1136/heartjnl-2014-305693.
9
Statins: new American guidelines for prevention of cardiovascular disease.他汀类药物:美国预防心血管疾病的新指南
Lancet. 2013 Nov 30;382(9907):1762-5. doi: 10.1016/S0140-6736(13)62388-0. Epub 2013 Nov 20.
10
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会心血管风险评估指南:美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73. doi: 10.1161/01.cir.0000437741.48606.98. Epub 2013 Nov 12.